After his inauguration, President Donald J. Trump signed an executive order ordering federal agencies to ease the burden of his predecessor’s landmark healthcare law.
During his campaign, President Donald J. Trump promised that repealing the Affordable Care Act (ACA) would be the first order of business, and he kept that promise. After his inauguration, Trump signed an executive order ordering federal agencies to ease the burden of his predecessor’s landmark healthcare law.
The executive order outlined the intent for a “prompt repeal” of the ACA and until the law is repealed, Trump is calling for taking “all actions consistent with law to minimize the unwarranted economic and regulatory burdens of the Act.”
The order also called for easing financial and regulatory burdens on states, individuals and families, health insurers, healthcare providers, and other stakeholders through waiving, deferring, granting exemptions, and delaying the implementing of provisions of the ACA. According to the AP, this aspect of the executive order is aimed at the unpopular individual mandate, which requires individuals to purchase health insurance or pay a penalty.
The order directs federal agencies to stop issuing regulations to expand the law, and also directs the secretary of HHS and agencies to “provide greater flexibility to states and cooperate with them in implementing healthcare programs.”
The AP reported that the effect of this executive order on the ACA could take weeks to fully understand. Uncertainty remains as to what to expect of the impact on not only the individual insurance market, but the coverage status of millions of Americans—especially those of a lower socioeconomic status or with preexisting conditions, who could face a loss of coverage depending on which components of the ACA are eventually disbanded.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More